Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
The Oncologist
Published October 20, 2026
Characteristics and Outcomes of NATALEE- and monarchE-Eligible Early Breast Cancer in Finland: A ...
October 21, 2026
Medspoke
Medspoke
World Journal of Urology
Published October 20, 2026
00:00
--:--
Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer p...
October 21, 2026
Share
Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics.
https://www.medspoke.co/channel_journal?id=689&tap_id=16037
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
World Journal of Urology
Published October 20, 2026
Volumetric stone size assessment did not demonstrate improved prediction of treatment success com...
October 21, 2026
Why are you reporting this TALK?
